Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
49.31
-0.25 (-0.50%)
At close: Jun 16, 2026, 4:00 PM EDT
49.16
-0.15 (-0.30%)
Pre-market: Jun 17, 2026, 8:14 AM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $7.12 billion as of June 17, 2026. Its market cap has increased by 57.61% in one year.
Market Cap
7.12B
Enterprise Value
5.50B
1-Year Change
57.61%
Ranking
Category
Stock Price
$49.31
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $7.12B, an increase of 415.97%. That is a compound annual growth rate of 31.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 7.12B | 17.88% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 7.44B |
| Praxis Precision Medicines | 7.43B |
| Kymera Therapeutics | 7.09B |
| Protagonist Therapeutics | 7.06B |
| TG Therapeutics | 7.02B |
| Spyre Therapeutics | 7.02B |
| Immunovant | 6.90B |
| Legend Biotech | 6.66B |